DENVER, Colo., August 5, 2019- (24/7MarketNews via COMTEX) Venture Market News for August 5, 2019.
CytoDyn Granted Small Business Waiver of Application Fees by FDA for Leronlimab (PRO 140) BLA Filing
VANCOUVER, Washington, Aug. 05, 2019 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, today announced it was granted a small business waiver of application fees by the U.S. Food and Drug Administration (“FDA”) for the pending BLA filing for leronlimab as a combination therapy with HAART for HIV-infected patients.
MYM Finalizes 50% Acquisition of BioHemp Naturals
VANCOUVER, British Columbia, July 30, 2019 /CNW/ — MYM Nutraceuticals Inc., (CSE: MYM) (CSE: MYM.CN) (OTCBB: MYMMF) (“MYM” or “The Company”) is pleased to announce that the Company has finalized the acquisition of 50% of BioHemp Naturals (“BioHemp”), a licensed hemp cultivator in the business of cultivating and distributing CBD-rich hemp biomass to licensed producers in Canada. BioHemp co-founder, Len Atkinson, has joined the MYM management team as Global Hemp Project Manager.
Texas Mineral Resources Announces Strategic Investment by Navajo Transitional Energy Company
SIERRA BLANCA, TX, Aug. 05, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – Texas Mineral Resources Corp. (OTCQB: TMRC)
- Navajo Transitional Energy purchases 5.1 million TMRC shares @ $0.36 per share from the Company and separately will buy an additional 5.0 million shares from a current institutional shareholder
- TMRC expands board from 5 to 7 members and grants Navajo Transitional Energy two board seats
Texas Mineral Resources Corp. (TMRC), an exploration company targeting the heavy rare earths and a variety of other high-value elements and industrial minerals, is pleased to announce that the Navajo Transitional Energy Company (NTEC), a company formed under the laws of the Navajo Nation, has concluded a strategic transaction whereby NTEC has purchased a total of 5,111,626 newly issued TMRC shares at a price of $0.36 per share for a total of approximately $1.84 million of additional capital into TMRC. Separately, NTEC will purchase 5,000,257 shares in a private transaction from a current TMRC institutional shareholder. In total, NTEC’s 10,111,883 shares represent approximately 20% of TMRC’s currently outstanding shares.
Andrew Plank appointed President and General Manager of Roche Diagnostics Canada
LAVAL, QC, Aug. 5, 2019 /CNW Telbec/ – Roche Diagnostics Canada, a division of Hoffmann-La Roche Limited, leader in the field of in vitro diagnostics, announces the appointment of Andrew Plank as President and General Manager.
Connect with 24/7 Market News on social media:
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN provides comprehensive corporate communications resources and tools to engage the investment community.
24/7 Market News (24/7MN) is a third party publisher and news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7MN’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.
The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable. 24/7MN makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. 24/7MN and/or its affiliates are not responsible for any gains or losses that result from the opinions expressed and are not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.
For further information on 24/7 Market News, please go to www.247marketnews.com
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may,” “future,” “plan,” or “planned,” “will,” or “should,” “expected,” “anticipates,” “draft,” “eventually,” or “projected.” You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and 24/7MN undertakes no obligation to update such statements
24/7 Market News